Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.32 USD | -2.92% | -10.66% | -42.55% |
May. 06 | Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating | MT |
May. 02 | Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.55% | 864M | |
+23.55% | 46.71B | |
+48.83% | 41.8B | |
-0.97% | 41.52B | |
-5.86% | 29.55B | |
+11.25% | 25.78B | |
-21.00% | 19.26B | |
+3.18% | 12.14B | |
-2.70% | 12.08B | |
+30.04% | 11.98B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Insider Sell: Relay Therapeutics